Related Articles
Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer
Enhanced antitumor activity by the combination of dasatinib and combretastatin A-4 in vitro and in vivo
In vivo, <em>ex vivo</em> and <em>in vitro</em> dasatinib activity in chronic lymphocytic leukemia
Dendritic cell vaccine with Ag85A enhances anti‑colorectal carcinoma immunity
Immunological suppression of head and neck carcinoma by dendritic cell tumor fusion vaccine